Guardant Health
GH
#3260
Rank
A$5.55 B
Marketcap
$44.97
Share price
-3.64%
Change (1 day)
30.15%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of September 2024 : A$2.37 Billion

According to Guardant Health 's latest financial reports the company's total assets are A$2.37 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$2.62 B10.83%
2022-12-31A$2.36 B-22.19%
2021-12-31A$3.04 B2.92%
2020-12-31A$2.95 B114.91%
2019-12-31A$1.37 B64.88%
2018-12-31A$0.83 B89.82%
2017-12-31A$0.43 B171.64%
2016-12-31A$0.16 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
A$2.34 B-1.41%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.95 B 192.65%๐Ÿ‡บ๐Ÿ‡ธ USA